Helicobacter pylori eradication as exclusive treatment for limited-stage gastric diffuse large B-cell lymphoma: results of a multicenter phase 2 trial-Reference-Cited by-同舟云学术

Helicobacter pylori eradication as exclusive treatment for limited-stage gastric diffuse large B-cell lymphoma: results of a multicenter phase 2 trial

Published:2012-11-01 Issue:18 Volume:120 Page:3858-3860
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Ferreri Andrés J. M.¹,Govi Silvia¹,Raderer Markus²,Mulè Antonino³,Andriani Alessandro⁴,Caracciolo Daniele⁵,Devizzi Liliana⁶,Ilariucci Fiorella⁷,Luminari Stefano⁸,Viale Edi⁹,Müllauer Leonhard¹⁰,Dell'Oro Stefania¹,Arcidiacono Paolo Giorgio⁹,Ponzoni Maurilio¹¹¹²,Patti Caterina¹¹³

Affiliation:

1. Unit of Lymphoid Malignancies, Department of Oncohematology, San Raffaele Scientific Institute, Milan, Italy

2. Department of Internal Medicine, University of Vienna, Vienna, Austria

3. Division of Hematology, Ospedale Cervello, Palermo, Italy

4. Division of Gastroenterology, Ospedale Regina Margherita, Rome, Italy

5. Division of Hematology, Azienda Ospedaliera e Universitaria San Giovanni Battista, Turin, Italy

6. Oncologia Medica 3, Istituto Nazionale dei Tumori, Milan, Italy

7. Divisione di Ematologia, AO Santa Maria Nuova, Reggio Emilia, Italy

8. Dipartimento di Oncologia, Ematologia e Malattie dell'Apparato Respiratorio, Università di Modena e Reggio Emilia, Modena, Italy

9. Gastroenterology Unit, San Raffaele Scientific Institute, Milan, Italy

10. Institute of Pathology, University of Vienna, Vienna, Austria

11. M.P. and C.P. share senior authorship.